| Date | Title | Description |
| 26.05.2026 | DOSIsoft Launches DOSIsoft Theranostics, a Dedicated Entity to Accelerate Software Innovation for Personalized Nuclear Medicine and Theranostics | PARIS, May 26, 2026 /PRNewswire/ -- Ahead of SNMMI 2026, DOSIsoft, a leading provider of dosimetry software for radiation oncology and nuclear medicine, today announced the launch of DOSIsoft Theranostics, a dedicated entity focused on deve... |
| 19.05.2026 | Gustave Roussy and One Biosciences Partner to Bring Single Cell to Clinical Practice for Precision Oncology | Gustave Roussy partners with One Biosciences, a techbio company that harnesses single cell technology and AI to develop advanced precision diagnostics. The collaboration aims to further demonstrate the feasibility and impact of integrating ... |
| 07.05.2026 | Signadori Bio: €11.1 Million Seed Round Raised For Monocyte Immunotherapy Platform Targeting Solid Tumors | Signadori Bio announced the completion of a seed extension financing round, bringing the company’s total funding to €11.1 million. The latest investment included participation from Taiho Ventures along with existing investors Sofinnova Part... |
| 13.03.2026 | Waiv Secures $33 Million to Revolutionize Cancer Diagnostics with AI | Waiv, an AI precision testing innovator, recently secured $33 million in funding. This Paris-based company spun out from Owkin. It transforms cancer diagnostics. Waiv's powerful AI analyzes digital histopathology and multimodal clinical dat... |
| 12.03.2026 | Waiv Secures $33 Million to Scale AI Precision Testing | Waiv, a Paris-based company catalyzing AI precision testing, today announced a $33 million financing round to accelerate the global deployment of its AI precision testing platform. The financing marks Waiv’s spin out from Owkin, where its e... |
| 12.03.2026 | Waiv: $33 Million Raised For AI Precision Oncology Testing Platform | Waiv, a Paris-based developer of AI-powered precision oncology testing technology, announced it has raised $33 million in financing to accelerate global deployment of its AI precision testing platform and expand its clinical-grade diagnosti... |
| 25.02.2026 | Discovery linking gut bacteria to cancer treatment wins the Bial Award in Biomedicine and earns €350,000 prize | A study published in Science reveals that a healthy gut microbiota can enhance the efficacy of immunotherapy used to treat cancer, while antibiotics may impair its effect by reducing intestinal microbiota diversity.
PORTO, Portugal, Feb. 25... |
| 17.02.2026 | Lytix Biopharma Publishes Comprehensive Review on the Transformative Potential of Oncolytic Peptides in Leading Cancer Journal (JITC) | Lytix Biopharma Publishes Comprehensive Review on the Transformative Potential of Oncolytic Peptides in Leading Cancer Journal (JITC)
Tue, Feb 17, 2026 08:53 CET Report this content
OSLO, Norway, February 17, 2026 — Lytix Biopharma AS (“Lyt... |
| 01.02.2026 | Demystifying Quantitative Finance: How Abdelmadjid Laouedj Turns Complex Math into Real-World Impact | Share
Share
Share
Share
Email
By applying quantitative models, he once cut hospital forecasting errors to within 10%, the same skills he now uses to shape risk management at one of world’s largest banks
In April 2025, the International Mone... |
| 30.10.2025 | Clinical Late-Breaking Abstracts Announced for the Society for Immunotherapy of Cancer's 40th Anniversary Annual Meeting | The Society for Immunotherapy of Cancer (SITC) received an incredible number of abstract submissions in 2025, more than 1,300, including many clinical based Late-breaking Abstracts. SITC is proud to announce the titles and authors for the c... |
| 04.09.2025 | ArcaScience Secures $7M to Revolutionize Drug Evaluation with AI | ArcaScience secured $7M seed funding. This investment propels AI-driven drug benefit-risk evaluation. The company will expand US and UK operations, launching crucial patient solutions. Focus areas include pediatric brain cancer and dermatol... |
| 03.09.2025 | ArcaScience raises $7M to transform drug development with AI-driven insights | AI healthtech startup ArcaScience has raised $7 million in seed funding to expand in the US and UK, launch patient solutions, and advance safer drug evaluation.
The round was led by The Moon Venture, with participation from Pléiade Venture,... |
| 17.07.2025 | One Biosciences Raises €15M in Series A Funding | One Biosciences, a Paris, France-based precision oncology techbio company, raised €15M in Series A funding.
The round was led by Redmile Group and Blast, with participation from Galion.exe, Invus, Adamed Technology, Sofinnova Partners, Poly... |
| 17.07.2025 | One Biosciences raises €15M Series A to advance precision oncology platform | One Biosciences, a precision oncology biotech company pioneering clinical grade single-cell tumour profiling, today announced €15 million Series A financing, bringing the company’s funding to €20 million.
One Biosciences aims to help clinic... |
| 17.04.2025 | Saudi Arabia and France Strengthen Health Cooperation Through Strategic Agreements in Biotech and Digital Health | PARIS, April 17, 2025 /PRNewswire/ -- On the second day of an official visit to France, His Excellency Fahad Abdulrahman AlJalajel, Minister of Health of the Kingdom of Saudi Arabia, held bilateral meetings with senior French officials incl... |
| 21.03.2025 | The Biotech Boom and the Opioid Reckoning: A Tale of Two Industries | In the heart of Europe, a new wave of biotech innovation is rising. Sofinnova Partners has closed a €165 million fund, the Sofinnova Biovelocita II. This fund is a beacon for startups, illuminating the path for groundbreaking therapies. It’... |
| 19.03.2025 | Sofinnova Partners: €165M Biotech Acceleration Fund Closed | Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London, and Milan, announced the final close of Sofinnova Biovelocita II. This fund has exceeded its target, successfully raising €165 million, with s... |
| 28.01.2025 | SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities | The cutting-edge OncoPortal™ Mutation Tracker add-on module enables precision monitoring of evolving genomic cancer drivers
BOSTON, MA and ROLLE, Switzerland, Jan. 28, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native heal... |
| 03.12.2024 | Paris-based Orakl Oncology raises €11 million to launch AI-powered drug development tools | Orakl Oncology, a French oncology startup focused on cancer drug development, has secured €11 million in seed funding.
The round was led by Singular with participation from Bpifrance, including the Grand Prix i Lab, and existing investors. ... |
| 03.12.2024 | Orakl Oncology raises €11M to launch AI-powered drug development products | Orakl Oncology, a precision oncology company, has raised €11M seed funding round led by Singular, with support from Bpifrance including the Grand Prix i-Lab, and participation from existing investors.
This capital will be used to accelerate... |
| 02.10.2024 | Owkin Partners with AstraZeneca for Advanced AI gBRCA Pre-Screening | Share
Tweet
Share
Share
Email
Owkin has partnered with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer.
Takeaway Points Owkin has partnered with AstraZeneca to develop an AI gBRCA pre-screen solution for breast canc... |
| 05.08.2024 | SITC Announces 2024 Class of Fellows to the Academy of Immuno-Oncology | Academy of Immuno-Oncology
The Society for Immunotherapy of Cancer (SITC) announces the 2024 Class of Fellows of the Academy of Immuno-Oncology (FAIO). The luminaries of the 2024 class will be inducted at an event during SITC's 39th Annual ... |
| 12.07.2024 | Spotlight Medical Secures €6.2M in Seed Funding to Enhance Cancer Treatment Strategies with AI-Powered Prognosis Tests | PARIS–(BUSINESS WIRE)–July 12, 2024–
Spotlight Medical, a pioneering startup developing AI-driven prognosis tests to assist physicians in selecting the most effective treatment for cancer patients, today announced that it has raised €6.2 mi... |
| 13.07.2023 | Gustave Roussy and THERYQ: France welcomes the first FLASH radiotherapy machine to treat patients | PEYNIER, France, July 13, 2023 /PRNewswire/ -- Gustave Roussy and THERYQ announce a strategic and structuring partnership to roll out and assess FLASH technology for radiotherapy. French medical technology company THERYQ, specializing in pa... |
| 30.03.2023 | French AI biotech unicorn Owkin has launched a €33 million AI-powered precision medicine project for cancer diagnosis and treatment | Paris-based AI biotech unicorn Owkin has launched a €33million AI-powered precision medicine project, PortrAIt which has been backed by the French Government.
The collaboration will see France’s best research hospitals working with Owkin an... |
| 07.09.2021 | Speeding up Breast Cancer Diagnosis in Egypt: GE Healthcare, Gustave Roussy and the Egypt Ministry of Health Partner to… | Cairo, Egypt and Villejuif & Buc, France - September 7, 2021 - GE Healthcare, Gustave Roussy and the Egypt Ministry of Health (MOH) signed a preliminary agreement leveraging Gustave Roussy's One Stop Breast Cancer diagnostics program to... |
| 26.09.2014 | Cancer Core Europe: institutes unite across Europe to tackle cancer | Cancer Core Europe: institutes unite across Europe to tackle cancer
26-09-2014
Launched today (26 September), Cancer Core Europe brings together six cancer centres – including the Cambridge Cancer Centre at the University of Cambridge – to ... |
| - | French startup scoops up €40 million to take on cancer with remote patient monitoring | French health tech startup specialising in remote monitoring and therapeutic follow-up of cancer patients, Resilience has announced €40 million funding in a Series A. The funding will enable the platform to accelerate the deployment of its ... |
